These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36658044)
21. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624 [TBL] [Abstract][Full Text] [Related]
22. Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Erdem R; De Coster I; Withanage K; Mercer LD; Marchant A; Taton M; Cools N; Lion E; Cassels F; Higgins D; Ivinson K; Locke E; Mahmood K; Wright PF; Gast C; White JA; Ackerman ME; Konopka-Anstadt JL; Mainou BA; Van Damme P Vaccine; 2023 Mar; 41(10):1657-1667. PubMed ID: 36746739 [TBL] [Abstract][Full Text] [Related]
23. Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial. Crothers JW; Ross Colgate E; Cowan KJ; Dickson DM; Walsh M; Carmolli M; Wright PF; Norton EB; Kirkpatrick BD Vaccine; 2022 Apr; 40(19):2705-2713. PubMed ID: 35367069 [TBL] [Abstract][Full Text] [Related]
24. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli. Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449 [TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial. Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774 [TBL] [Abstract][Full Text] [Related]
26. Immunization with Salmonella Enteritidis secreting mucosal adjuvant labile toxin confers protection against wild type challenge via augmentation of CD3 Lalsiamthara J; Lee JH Vaccine; 2017 Feb; 35(5):767-773. PubMed ID: 28063704 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4 Frederick DR; Goggins JA; Sabbagh LM; Freytag LC; Clements JD; McLachlan JB Mucosal Immunol; 2018 Mar; 11(2):549-561. PubMed ID: 28792004 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine. Chaudhari AA; Lee JH Avian Pathol; 2013 Aug; 42(4):365-72. PubMed ID: 23815619 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379 [TBL] [Abstract][Full Text] [Related]
40. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling. Larena M; Holmgren J; Lebens M; Terrinoni M; Lundgren A J Immunol; 2015 Apr; 194(8):3829-39. PubMed ID: 25786687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]